Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)

NCT04962711 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.

NCT NCT04962711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04962711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk-guided Disease Management Plan to Prevent Heart Failure in Patients Treated With Previous Chemotherapy (REDEEM)
Lead sponsor
Baker Heart and Diabetes Institute
Phase
Not applicable
Overall status
Recruiting
Start date
March 30, 2023
Completion date
December 31, 2025
Enrollment
685 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure